Interacting Drugs |
Cyproterone and ethinyl estradiol vs HMG-CoA Reductase Inhibitors |
Security Level |
 |
Mechanism |
HMG-CoA Reductase Inhibitors: Cyproterone may increase the serum concentration of HMG-CoA Reductase Inhibitors. |
Management |
Avoid use of statins metabolized by CYP3A4 (eg, simvastatin) and consider avoiding fluvastatin as well in patients receiving high dose cyproterone (300 mg/day). Consider use of pravastatin, rosuvastatin, or pitavastatin if statin therapy is needed. Exceptions: Pitavastatin; Pravastatin; Rosuvastatin. |
Cyproterone and ethinyl estradiol vs HMG-CoA Reductase Inhibitors
Post Review about Cyproterone and ethinyl estradiol vs HMG-CoA Reductase Inhibitors Click here to cancel reply.
Other Interactions of Cyproterone and ethinyl estradiol
Other Interactions of HMG-CoA Reductase Inhibitors
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.